Plasmune [formerly Foalimmune (Equine IgG)]This page contains information on Plasmune [formerly Foalimmune (Equine IgG)] for veterinary use.
The information provided typically includes the following:
- Plasmune [formerly Foalimmune (Equine IgG)] Indications
- Warnings and cautions for Plasmune [formerly Foalimmune (Equine IgG)]
- Direction and dosage information for Plasmune [formerly Foalimmune (Equine IgG)]
Plasmune [formerly Foalimmune (Equine IgG)]This treatment applies to the following species:
For Veterinary Use, Not Intended for Humans
For intravenous use in the treatment of the failure of passive transfer in the equine neonate at a dose of 20ml/kg of body weight. The diagnosis of failure of passive transfer should be established from a blood sample taken 18 hours after birth.
KEEP FROZEN AT ≤-15°C UNTIL USE. Thaw quickly in warm water not exceeding 110°F. DO NOT MICROWAVE. Administer as soon as possible after thawing to body temperature by filtered intravenous infusion at a maximum rate of 20ml/kg (shock bolus) over a period of 15-20 minutes. Do not mix with other products, except as specified on the label.
In case of a reaction, marked most often by tenesmus and hyperventilation, slow the speed of administration. If this does not abate the signs, stop administration until signs abate and continue at a slower rate. If signs persist, suspend administration and treat with histamine blockers and anti-inflammatory agents. Discard any unused portion.
Each single dose bag contains plasma as a source of Rhodococcus equi antibodies with sodium citrate as an anticoagulant derived from healthy horses with Aa and Ca r.b.c. antigens and no r.b.c antibodies. All donor horses are negative for EVA, Dourine, Brucellosis, Piroplasmosis and Glanders. This product is free of Equine Parvovirus-Hepatitis and Equine Infectious Anemia. There is no preservative added.
CAUTION: Anaphylaxis may occur. This product has not been processed by heating or treating with ionizing radiation and may be capable of spreading disease. The use of equine serum and plasma products has been associated with hepatitis (Theiler’s Disease). This product has not been tested in pregnant animals. In case of human exposure contact a physician.
US Vet. Lic. No. 318, Product Code 3607.01
LAKE IMMUNOGENICS, INC. ONTARIO, NY 14519
348 BERG ROAD, ONTARIO, NY, 14519
|Every effort has been made to ensure the accuracy of the Plasmune [formerly Foalimmune (Equine IgG)] information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2021 Animalytix LLC. Updated: 2021-10-04